Gold prices rebound as risk-off mood grips markets
Orgenesis Inc . (NASDAQ:OTC:ORGS), a biotechnology company with a market capitalization of $5.78 million and significant operational challenges according to InvestingPro data, reported the resignation of its Chief Financial Officer and three directors, according to a press release statement filed with the Securities and Exchange Commission.
On August 8, Victor Miller resigned with immediate effect from his roles as Chief Financial Officer, Treasurer, and Secretary of Orgenesis Inc. The company stated that Mr. Miller’s departure was to pursue other opportunities and was not the result of any disagreement with the company, its management, or its board of directors regarding operations, policies, or practices.
On August 9, Yaron Adler and Adam Pelavin each notified Orgenesis of their immediate resignation from the board of directors. The company reported that these resignations were not related to any disagreements with management or the board concerning company operations, policies, or practices.
On August 18, Santhosh Nagaraja also resigned as a director of Orgenesis, effective immediately. The company stated that Mr. Nagaraja’s resignation was not due to any disagreement with management or the board on matters related to operations, policies, or practices.
Orgenesis Inc. is listed on the Nasdaq Capital Market under the ticker ORGS. All information is based on a press release statement included in the company’s filing with the Securities and Exchange Commission.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.